Clinical Trial Update: A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of ALE.F02 in adults with advanced liver fibrosis or mild cirrhosis has completed, with an update on its results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Liver Fibrosis

Drugs mentioned

• ALE.F02

Snippet

Sponsor: Alentis Therapeutics AG | Conditions: Advanced Liver Fibrosis, Liver Cirrhosis | Phase 1 | Status: COMPLETED